Book contents
- Violence in Psychiatry
- Violence in Psychiatry
- Copyright page
- Contents
- Contributors
- Section 1 Statement of the problem
- Section 2 Assessment
- Section 3 Neurobiology
- Section 4 Guidelines
- Section 5 Psychopharmacology
- Section 6 Treatment interventions
- Chapter 24 A new standard of care for forensic mental health treatment: prioritizing forensic intervention
- Chapter 25 Forensic‐focused treatment planning: a new standard for forensic mental health systems
- Chapter 26 Implementing an ecological approach to violence reduction at a forensic psychiatric hospital: approaches and lessons learned
- Chapter 27 The appropriateness of treating psychopathic disorders
- Chapter 28 Psychosocial approaches to violence and aggression: contextually anchored and trauma-informed interventions
- Chapter 29 Comorbid mental illness and criminalness: implications for housing and treatment
- Chapter 30 Crime, violence, and behavioral health: collaborative community strategies for risk mitigation
- Chapter 31 New technologies in the management of risk and violence in forensic settings
- Chapter 32 Risk reduction treatment of psychopathy and applications to mentally disordered offenders
- Index
- References
Chapter 27 - The appropriateness of treating psychopathic disorders
from Section 6 - Treatment interventions
Published online by Cambridge University Press: 19 October 2021
Book contents
- Violence in Psychiatry
- Violence in Psychiatry
- Copyright page
- Contents
- Contributors
- Section 1 Statement of the problem
- Section 2 Assessment
- Section 3 Neurobiology
- Section 4 Guidelines
- Section 5 Psychopharmacology
- Section 6 Treatment interventions
- Chapter 24 A new standard of care for forensic mental health treatment: prioritizing forensic intervention
- Chapter 25 Forensic‐focused treatment planning: a new standard for forensic mental health systems
- Chapter 26 Implementing an ecological approach to violence reduction at a forensic psychiatric hospital: approaches and lessons learned
- Chapter 27 The appropriateness of treating psychopathic disorders
- Chapter 28 Psychosocial approaches to violence and aggression: contextually anchored and trauma-informed interventions
- Chapter 29 Comorbid mental illness and criminalness: implications for housing and treatment
- Chapter 30 Crime, violence, and behavioral health: collaborative community strategies for risk mitigation
- Chapter 31 New technologies in the management of risk and violence in forensic settings
- Chapter 32 Risk reduction treatment of psychopathy and applications to mentally disordered offenders
- Index
- References
Summary
A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
- Type
- Chapter
- Information
- Violence in Psychiatry , pp. 269 - 278Publisher: Cambridge University PressPrint publication year: 2016
References
Saß, H, Felthous, AR. Introduction to Volume 1. In: Felthous, AR, Saß, H, eds. The International Handbook of Psychopathic Disorders and the Law, Volume I: Diagnosis and Treatment. Chichester, UK: John Wiley and Sons, Ltd.; 2007: 1–5.Google Scholar
Saß, H, Felthous, AR. History and development of psychopathic disorders. In: Felthous, AR, Saß, H, eds. The International Handbook of Psychopathic Disorders and the Law, Volume I: Diagnosis and Treatment. Chichester, UK: John Wiley and Sons, Ltd.; 2007: 9–30.Google Scholar
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th edn. Washington, DC: Arlington, VA; 2013.Google Scholar
Felthous, AR, Sass, H. Behandlungsprogramme für Straftäter in den Vereinigten Staaten und Kanada. In: Kröber, HL, Dölling, D, Leygraf, N, Sass, H, eds. Handbuch der Forensischen Psychiatrie, Band 3, Psychiatrische Kriminalprognose und Kriminaltherapie. Darmstadt, Germany: Steinkoff; 2006: 390–412.Google Scholar
Rice, ME, Harris, GT, Cormier, C. Evaluation of a maximum security therapeutic community for psychopaths and other mentally disordered offenders. Law Hum. Behavior. 1992; 16(4): 399–412.Google Scholar
Skeem, JL, Monahan, J, Mulvey, EP. Psychopathy, treatment and involvement, and subsequent violence among civil psychiatric patients. Law Hum. Behavior. 2002; 26(6): 577–603.Google Scholar
Felthous, AR. The “untreatability” of psychopathy and hospital commitment in the USA. Int. J. Law Psychiatry. 2011; 34(6): 400–405.Google Scholar
Seto, MC, Barbaree, HE. Psychopathy, treatment behavior and sex offender recidivism. J. Interpers. Violence. 1999; 14(12): 1235–1248.Google Scholar
Barbaree, HE. Psychopathy, treatment behavior and recidivism: an extended follow-up of Seto and Barbaree. J. Interpers. Violence. 2005; 20(9): 1115–1131.Google Scholar
Hare, RD. Psychological instruments in the assessment of psychopathy. In: Felthous, AR, Saß, H, eds. The International Handbook of Psychopathic Disorders and the Law, Volume I: Diagnosis and Treatment. Chichester, UK: John Wiley and Sons, Ltd.; 2007: 41–67.Google Scholar
Looman, J, Abracen, J, Serin, R, Marquis, P. Psychopathy, treatment change and recidivism in high risk high need sexual offenders. J. Interpers. Violence. 2005; 20(5): 549–568.Google Scholar
Salekin, RT, Worley, C, Grimes, RD. Treatment of psychopathy: a review and brief introduction to the mental model approach for psychotherapy. Behav. Sci. Law. 2010; 28(2): 235–266.Google Scholar
D’Silva, K, Duggan, D, McCarthy, L. Does treatment really make psychopaths worse? A review of the evidence. J. Personal. Disord. 2004; 18(2): 163–177.Google Scholar
Hare, RD. The Hare Psychopathy Checklist – Revised. Toronto, Canada: Multi-Health Systems; 1991.Google Scholar
Hare, RD. Without Conscience: The Disturbing World of the Psychopaths Among Us. New York: Guilford Press; 1998.Google Scholar
Cornell, D, Warren, J, Hawk, G, et al. Psychopathy in instrumental and reactive offenders. J. Consult. Clin. Psychol. 1996; 64(4): 783–790.Google Scholar
Patrick, CJ. Emotional processes in psychopathy. In: Raine, A, Sanmartin, J, eds. Violence and Psychopathy. New York: Kluwer/ Plenum; 2001: 57–77.Google Scholar
Raine, A, Yang, Y. The neuroanatomical bases of psychopathy: a review of brain imaging findings. In: Patrick, CJ, ed. Handbook of Psychopathy. New York: Guilford; 2006: 278–295.Google Scholar
Felthous, AR. Schizophrenia and impulsive aggression: a heuristic inquiry with forensic and clinical implications. Behav. Sci. Law. 2008; 26(6): 735–758.Google Scholar
Babiak, P, Hare, RD. Snakes in Suits: When Psychopaths Go to Work. New York: Harper-Collins; 2006.Google Scholar
Babiak, P. When psychopaths go to work: a case study of an industrial psychopath. Applied Psychology. 1995; 44(2): 171–188.Google Scholar
Babiak, P. Psychopathic manipulation at work. In: Gacono, CB, ed. The Clinical and Forensic Assessment of Psychopathy: A Practitioner’s Guide. Mahwah, NJ: Erlbaum; 2000: 287–311.Google Scholar
Babiak, P, Neumann, CS, Hare, RD. Corporate psychopathy: talking the walk. Behav. Sci. Law. 2010; 28(2): 174–193.Google Scholar
Barratt, ES, Standford, MS, Felthous, AR, Kent, TA. The effects of phenytoin on impulsive and premeditated aggression: a controlled study. J. Clin. Psychopharmacol. 1997; 17(5): 341–349.Google Scholar
Barratt, ES, Stanford, MS, Kent, TA, Felthous, A. Neurological and cognitive psychophysiological substrates of impulsive aggression. Biol. Psychiatry. 1997; 41(10): 1045–1061.Google Scholar
Felthous, AR. The pharmacotherapy of impulsive aggression. In: Thienhaus, OJ, Piaski, M, eds. Correctional Psychiatry: Practice Guidelines and Strategies, Volume II. Kingston, NJ: Civil Research Institute; 2013: 4-1–4-34.Google Scholar
Glancy, GD, Knott, TF. Part I: The psychopharmacology of long-term aggression—toward an evidence-based algorithm. CPA Bulletin. 2002; 34(6).Google Scholar
Glancy, GD, Knott, TF. Part II: The psychopharmacology of long-term aggression—toward an evidence-based algorithm. CPA Bulletin. 2002; 34(6).Google Scholar
Glancy, GD, Knott, TF. Part III: The psychopharmacology of long-term aggression—toward an evidence-based algorithm. CPA Bulletin. 2003; 35(1): 18.Google Scholar
Moeller, FG, Swann, A. Pharmacotherapy of clinical aggression in individuals with psychopathic disorders. In: Felthous, AR, Saß, H, eds. The International Handbook of Psychopathic Disorders and the Law, Volume I: Diagnosis and Treatment. Chichester, UK: John Wiley & Sons, Ltd.; 2007: 397–416.Google Scholar
Babiak, P. From darkness into the light: psychopathy in industrial and organizational psychology. In: Hervé, H, Yville, C, eds. The Psychopath: Theory, Research and Practice. Mahwah, NJ: Erlbaum; 2007: 411–428.Google Scholar
Gao, Y, Raine, A. Successful and unsuccessful psychopaths: a neurobiological model. Behav. Sci. Law. 2010; 28(2): 194–210.Google Scholar
Taylor, BP, Weiss, M, Ferretti, CJ, et al. Disruptive, impulse-control, and conduct disorders. In: Hales, RE, Yudofsky, SC, Roberts, LW, eds. American Psychiatric Publishing Textbook of Psychiatry, 6th edn. Washington, DC: American Psychiatric Publishing; 2014: 703–734.Google Scholar
Hollander, E, Tracy, KA, Swann, AC, et al. Divalproex in the treatment of impulsive aggression: efficacy in cluster B personality disorder. Neuropsychopharmacology. 2003; 28(6): 1186–1197.Google Scholar
Hollander, E, Swann, AC, Coccaro, EF, Jiang, P, Smith, TB. Impact of trait impulsivity and state aggression in divalproex versus placebo response in borderline personality disorder. Am. J. Psychiatry. 2005; 162(3): 621–624.Google Scholar
Felthous, AR, Saß, H, eds. The International Handbook of Psychopathic Disorders and the Law, Volume I: Diagnosis and Treatment. Chichester, UK: John Wiley and Sons, Ltd.; 2007.Google Scholar
Comai, S, Tau, M, Gobbi, G. The psychopharmacology of aggressive behavior: a translational approach. Part 1: Neurobiology. J. Clin. Psychopharmacol. 2012; 32(1): 83–94.Google Scholar
Comai, S, Tau, M, Pavlovic, Z, Gobbi, G. The psychopharmacology of aggressive behavior: a translational approach. Part 2: Clinical studies using atypical antipsychotics, anticonvulsants, and lithium. J. Clin. Psychopharmacol. 2012; 32(2): 237–260.Google Scholar
Blair, JR. Neurobiological basis of psychopathy. Br. J. Psychiatry. 2003; 182(1): 5–7.Google Scholar
Siever, LJ, Buchsbaum, MS, New, AS, et al. D,l-fenfluramine response in impulsive personality disorder assessed with [18F] fluorodeoxyglucose positron emission tomography. Neuropsychopharmacology. 1999; 20(5): 413–423.Google Scholar
Cooke, DS, Mitchie, C, Hart, SD, Hare, RD. Evaluating the Screening Version of the Hale Psychopathy Checklist—Revised (PCL-SV). Psychol. Assess. 1999; 11(1): 3–13.Google Scholar
van de Giessen, E, Rosell, DR, Thompson, JL, et al. Serotonin transporter availability in impulsive aggressive personality disordered patients: a PET study with [11C] DASB. J. Psychiatr. Res. 2014; 58: 147–154.Google Scholar
Dolan, MC, Anderson, IM. The relationship between serotonergic function and the Psychopathy Checklist: Screening Version. J. Psychopharmacol. 2003; 17(2): 216–222.Google Scholar
Felthous, AR, Lake, SL, Rundle, BK, Stanford, MS. Pharmacotherapy of impulsive aggression: a quality comparison of controlled studies. J. Int. Law Psychiatry. 2013; 36(3–4): 258–263.Google Scholar
Felthous, AR, Barratt, ES. Impulsive aggression. In: Coccaro, EF, ed. Aggression: Psychiatric Assessment and Treatment. New York: Marcel Dekker; 2003: 123–148.Google Scholar
Felthous, AR, Stanford, MS. A proposed algorithm for the pharmacotherapy of impulsive aggression. J. Am. Acad. Psychiatry Law. 2015; 43(4): 456–467.Google Scholar
Coccaro, EF, Kavoussi, RJ. Fluoxetine and impulsive aggressive behavior in personality disordered subjects. Arch. Gen. Psychiatry. 1997; 54(12): 1081–1088.Google Scholar
Jones, RM, Arlidge, J, Gilham, S, et al. Efficacy of mood stabilizers in the treatment of impulsive or repetitive aggression: systematic review and meta-analysis. Br. J. Psychiatry. 2011; 198(2): 93–98.Google Scholar
Hollander, E, Swann, AC, Coccaro, EF, Jiang, P, Smith, TB. Impact of trait impulsivity and state aggression on divalproex versus placebo response in borderline personality disorder. Am. J. Psychiatry. 2005; 162(3): 621–624.Google Scholar
Mattes, JA. Levetiracetam in patients with impulsive aggression: a double-blind, placebo-controlled trial. J. Clin. Psychiatry. 2008; 69(2): 310–315.Google Scholar
Stanford, MS, Helfritz, LE, Conklin, SM, et al. A comparison of anticonvulsants in the treatment of impulsive aggression. Exp. Clin. Psychopharmacol. 2005; 13(1): 72–77.Google Scholar
Cueva, JE, Overall, JE, Small, AM, et al. Carbamazepine in aggressive children with conduct disorder: a double-blind and placebo-controlled study. J. Am. Acad. Child. Adolesc. Psychiatry. 1996; 35(4): 480–490.Google Scholar
Mattes, JA. Oxcarbazepine in patients with impulsive aggression: a double-blind, placebo-controlled trial. J. Clin. Psychopharmacol. 2005; 25(6): 575–579.Google Scholar
Donovan, SJ, Stewart, JW, Nunes, EV, et al. Divalproex treatment for youth with explosive temper and mood lability: a double-blind, placebo-controlled crossover design. Am. J. Psychiatry. 2000; 157(5): 818–820.Google Scholar
Campbell, M, Adams, PB, Small, AM, et al. Lithium in hospitalized aggressive children with conduct disorder: a double-blind, placebo-controlled study. J. Am. Acad. Child. Adolesc. Psychiatry. 1995; 34(4): 445–453.Google Scholar
Campbell, M, Small, AM, Green, WH, et al. Behavioral efficacy of haloperidol and lithium carbonate: a comparison in hospitalized aggressive children with conduct disorder. Arch Gen Psychiatry. 1984; 41(7): 650–656.Google Scholar
Sheard, MH, Marini, JL, Bridges, CI, Wagner, E. The effect of lithium on impulsive aggression behavior in man. Am. J. Psychiatry. 1976; 133(12): 1409–1413.Google Scholar
Coccaro, EF, Lee, RJ, Kavoussi, RJ. A double-blind randomized, placebo-controlled trial of fluoxetine in patients with intermittent explosive disorder. J. Clin. Psychiatry. 2009; 70(5): 653–662.Google Scholar
Lee, R, Kavoussi, RJ, Coccaro, EF. Placebo-controlled, randomized trial of fluoxetine in the treatment of aggression in male intimate partner abuse. Int. Clin. Psychopharm. 2008; 23(6): 337–341.Google Scholar
Pritchard, WS, Barratt, ES, Faulk, DM, Brandt, ME, Bryant, SG. Effects of phenytoin on N100 augmenting/reducing and late positive complex of the event related potential: a topographical analysis. Neuropsychobiology. 1986; 15(3–4): 201–207.Google Scholar